UniProt ID | ML12B_HUMAN | |
---|---|---|
UniProt AC | O14950 | |
Protein Name | Myosin regulatory light chain 12B | |
Gene Name | MYL12B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 172 | |
Subcellular Localization | ||
Protein Description | Myosin regulatory subunit that plays an important role in regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. Phosphorylation triggers actin polymerization in vascular smooth muscle. Implicated in cytokinesis, receptor capping, and cell locomotion.. | |
Protein Sequence | MSSKKAKTKTTKKRPQRATSNVFAMFDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASLGKNPTDAYLDAMMNEAPGPINFTMFLTMFGEKLNGTDPEDVIRNAFACFDEEATGTIQEDYLRELLTTMGDRFTDEEVDELYREAPIDKKGNFNYIEFTRILKHGAKDKDD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Ubiquitination | SSKKAKTKTTKKRPQ CCCCCCCCCCCCCCC | 54.19 | 24816145 | |
10 | Phosphorylation | SKKAKTKTTKKRPQR CCCCCCCCCCCCCCH | 49.43 | - | |
11 | Phosphorylation | KKAKTKTTKKRPQRA CCCCCCCCCCCCCHH | 35.80 | 22817900 | |
13 | Ubiquitination | AKTKTTKKRPQRATS CCCCCCCCCCCHHHH | 68.19 | 24816145 | |
15 | Ubiquitination | TKTTKKRPQRATSNV CCCCCCCCCHHHHHH | 36.57 | 24816145 | |
18 | Phosphorylation | TKKRPQRATSNVFAM CCCCCCHHHHHHHHH | 15.33 | 32142685 | |
19 | Phosphorylation | KKRPQRATSNVFAMF CCCCCHHHHHHHHHC | 24.03 | 11384979 | |
20 | Phosphorylation | KRPQRATSNVFAMFD CCCCHHHHHHHHHCC | 29.97 | 11384979 | |
24 | Phosphorylation | RATSNVFAMFDQSQI HHHHHHHHHCCHHHH | 8.08 | 32142685 | |
25 | Phosphorylation | ATSNVFAMFDQSQIQ HHHHHHHHCCHHHHH | 2.30 | 32645325 | |
25 | Sulfoxidation | ATSNVFAMFDQSQIQ HHHHHHHHCCHHHHH | 2.30 | 21406390 | |
29 | Phosphorylation | VFAMFDQSQIQEFKE HHHHCCHHHHHHHHH | 30.97 | 30266825 | |
34 | Ubiquitination | DQSQIQEFKEAFNMI CHHHHHHHHHHHHHH | 5.06 | 23503661 | |
35 | Ubiquitination | QSQIQEFKEAFNMID HHHHHHHHHHHHHHH | 47.59 | 23503661 | |
40 | Ubiquitination | EFKEAFNMIDQNRDG HHHHHHHHHHCCCCC | 2.63 | 23503661 | |
40 | Sulfoxidation | EFKEAFNMIDQNRDG HHHHHHHHHHCCCCC | 2.63 | 21406390 | |
50 | Ubiquitination | QNRDGFIDKEDLHDM CCCCCCCCHHHHHHH | 46.13 | 23000965 | |
51 | 2-Hydroxyisobutyrylation | NRDGFIDKEDLHDML CCCCCCCHHHHHHHH | 48.59 | - | |
51 | Acetylation | NRDGFIDKEDLHDML CCCCCCCHHHHHHHH | 48.59 | 25825284 | |
51 | Ubiquitination | NRDGFIDKEDLHDML CCCCCCCHHHHHHHH | 48.59 | 23000965 | |
56 | Ubiquitination | IDKEDLHDMLASLGK CCHHHHHHHHHHCCC | 40.88 | 23000965 | |
60 | Phosphorylation | DLHDMLASLGKNPTD HHHHHHHHCCCCHHH | 33.42 | 20068231 | |
97 | Phosphorylation | FGEKLNGTDPEDVIR HHHHHCCCCHHHHHH | 47.51 | 21712546 | |
109 | Glutathionylation | VIRNAFACFDEEATG HHHHHHHHCCCCCCC | 3.40 | 22555962 | |
128 | Phosphorylation | DYLRELLTTMGDRFT HHHHHHHHHCCCCCC | 27.62 | 30108239 | |
129 | Phosphorylation | YLRELLTTMGDRFTD HHHHHHHHCCCCCCH | 21.08 | 30108239 | |
130 | Sulfoxidation | LRELLTTMGDRFTDE HHHHHHHCCCCCCHH | 4.41 | 21406390 | |
133 | Methylation | LLTTMGDRFTDEEVD HHHHCCCCCCHHHHH | 30.54 | - | |
135 | Phosphorylation | TTMGDRFTDEEVDEL HHCCCCCCHHHHHHH | 43.31 | 30266825 | |
143 | Phosphorylation | DEEVDELYREAPIDK HHHHHHHHHHCCCCC | 12.36 | 30108239 | |
149 | Ubiquitination | LYREAPIDKKGNFNY HHHHCCCCCCCCCCC | 45.62 | 23000965 | |
150 | Ubiquitination | YREAPIDKKGNFNYI HHHCCCCCCCCCCCE | 64.40 | 23000965 | |
150 | Acetylation | YREAPIDKKGNFNYI HHHCCCCCCCCCCCE | 64.40 | 25953088 | |
151 | Acetylation | REAPIDKKGNFNYIE HHCCCCCCCCCCCEE | 56.17 | 26051181 | |
151 | Sumoylation | REAPIDKKGNFNYIE HHCCCCCCCCCCCEE | 56.17 | - | |
151 | Ubiquitination | REAPIDKKGNFNYIE HHCCCCCCCCCCCEE | 56.17 | 23000965 | |
151 | Sumoylation | REAPIDKKGNFNYIE HHCCCCCCCCCCCEE | 56.17 | - | |
155 | Ubiquitination | IDKKGNFNYIEFTRI CCCCCCCCCEEHHHH | 40.65 | 23000965 | |
156 | Ubiquitination | DKKGNFNYIEFTRIL CCCCCCCCEEHHHHH | 9.55 | 23000965 | |
156 | Phosphorylation | DKKGNFNYIEFTRIL CCCCCCCCEEHHHHH | 9.55 | 28796482 | |
160 | Phosphorylation | NFNYIEFTRILKHGA CCCCEEHHHHHHCCC | 12.19 | 28152594 | |
163 | Ubiquitination | YIEFTRILKHGAKDK CEEHHHHHHCCCCCC | 2.78 | 33845483 | |
164 | Ubiquitination | IEFTRILKHGAKDKD EEHHHHHHCCCCCCC | 37.31 | 33845483 | |
167 | Ubiquitination | TRILKHGAKDKDD-- HHHHHCCCCCCCC-- | 19.32 | 24816145 | |
168 | Ubiquitination | RILKHGAKDKDD--- HHHHCCCCCCCC--- | 70.65 | 24816145 | |
168 | Acetylation | RILKHGAKDKDD--- HHHHCCCCCCCC--- | 70.65 | 11920981 | |
169 | Ubiquitination | ILKHGAKDKDD---- HHHCCCCCCCC---- | 60.11 | 33845483 | |
173 | Ubiquitination | GAKDKDD-------- CCCCCCC-------- | 24816145 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
19 | T | Phosphorylation | Kinase | DAPK3 | O43293 | Uniprot |
19 | T | Phosphorylation | Kinase | ILK | Q13418 | PSP |
19 | T | Phosphorylation | Kinase | MAP3K12 | Q12852 | GPS |
19 | T | Phosphorylation | Kinase | MYLK | Q15746 | GPS |
19 | T | Phosphorylation | Kinase | ROCK1 | Q13464 | PSP |
19 | T | Phosphorylation | Kinase | MLCK | - | Uniprot |
20 | S | Phosphorylation | Kinase | AURKB | Q96GD4 | GPS |
20 | S | Phosphorylation | Kinase | DAPK1 | P53355 | PSP |
20 | S | Phosphorylation | Kinase | DAPK1 | Q80YE7 | PSP |
20 | S | Phosphorylation | Kinase | DAPK3 | O43293 | Uniprot |
20 | S | Phosphorylation | Kinase | ILK | Q13418 | PSP |
20 | S | Phosphorylation | Kinase | MAP3K12 | Q12852 | GPS |
20 | S | Phosphorylation | Kinase | MYLK | Q15746 | GPS |
20 | S | Phosphorylation | Kinase | ROCK1 | Q13464 | PSP |
20 | S | Phosphorylation | Kinase | MLCK | - | Uniprot |
135 | T | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ML12B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ML12B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PA2G4_HUMAN | PA2G4 | physical | 27173435 | |
TRAP1_HUMAN | TRAP1 | physical | 27173435 | |
SND1_HUMAN | SND1 | physical | 27173435 | |
CPSF6_HUMAN | CPSF6 | physical | 27173435 | |
UBE2N_HUMAN | UBE2N | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Epigallocatechin-3-O-gallate disrupts stress fibers and thecontractile ring by reducing myosin regulatory light chainphosphorylation mediated through the target molecule 67 kDa lamininreceptor."; Umeda D., Tachibana H., Yamada K.; Biochem. Biophys. Res. Commun. 333:628-635(2005). Cited for: PHOSPHORYLATION AT THR-19 AND SER-20. | |
"Phosphorylation of myosin II regulatory light chain is necessary formigration of HeLa cells but not for localization of myosin II at theleading edge."; Fumoto K., Uchimura T., Iwasaki T., Ueda K., Hosoya H.; Biochem. J. 370:551-556(2003). Cited for: PHOSPHORYLATION AT THR-19 AND SER-20, AND MUTAGENESIS OF19-THR-SER-20. | |
"Diphosphorylated MRLC is required for organization of stress fibersin interphase cells and the contractile ring in dividing cells."; Iwasaki T., Murata-Hori M., Ishitobi S., Hosoya H.; Cell Struct. Funct. 26:677-683(2001). Cited for: NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION AT THR-19 AND SER-20, ANDMUTAGENESIS OF 19-THR-SER-20. |